Predpokladaný rast EPS Q/Q spoločnosti Intercept Pharmaceuticals Inc

Aká je hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Intercept Pharmaceuticals Inc?

Hodnota metriky Predpokladaný rast EPS Q/Q spoločnosti Intercept Pharmaceuticals Inc je -68.29%

Aká je definícia metriky Predpokladaný rast EPS Q/Q?

Očakávaný rast EPS (Estimated quarterly EPS growth rate) z roka na rok je predpokladaný rast EPS spoločnosti za ďaľší kvartál v porovnaní s výsledkami z minulého kvartálu.

The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.

Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.

Čomu sa venuje spoločnosť Intercept Pharmaceuticals Inc?

we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.

Firmy s metrikou predpokladaný rast eps q/q podobnou spoločnosti Intercept Pharmaceuticals Inc